Literature DB >> 8401788

Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy.

P T Francis1, C Holmes, M T Webster, G C Stratmann, A W Procter, D M Bowen.   

Abstract

Non-Alzheimer's dementia due to lobar atrophy had choline acetyltransferase activities comparable with control rather than Alzheimer's disease values, based on 3 autopsy proven cases on Pick's disease and biopsies from 3 examples of dementia of frontal lobe type. Muscarinic cholinergic receptors were relatively spared only in Alzheimer's disease. Serotonin receptors were markedly reduced (based on Pick cases) whereas measures that reflected presynaptic serotonergic activity were either not affected or increased. Cerebrospinal fluid and brain tissue measurements suggested that inhibitory interneurones and dopamine release were relatively spared. There was no in vitro evidence of hypometabolism.

Entities:  

Mesh:

Year:  1993        PMID: 8401788     DOI: 10.1159/000107319

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  12 in total

1.  Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration.

Authors:  Tiffany W Chow; Mario F Mendez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2002 Sep-Oct       Impact factor: 2.035

Review 2.  The birth and early evolution of the frontotemporal dementia (FTD) concept.

Authors:  Arne Brun; Lars Gustafson
Journal:  J Mol Neurosci       Date:  2011-06-07       Impact factor: 3.444

Review 3.  Reward processing in neurodegenerative disease.

Authors:  David C Perry; Joel H Kramer
Journal:  Neurocase       Date:  2014-01-13       Impact factor: 0.881

Review 4.  Evaluation and management of the elderly patient presenting with cognitive complaints.

Authors:  Kerry L Hildreth; Skotti Church
Journal:  Med Clin North Am       Date:  2014-12-23       Impact factor: 5.456

Review 5.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia.

Authors:  Edward D Huey; Karen T Putnam; Jordan Grafman
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

Review 6.  Presenile dementia syndromes: an update on taxonomy and diagnosis.

Authors:  M D Greicius; M D Geschwind; B L Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

7.  The alpha(2) antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type.

Authors:  J T Coull; B J Sahakian; J R Hodges
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

8.  Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy.

Authors:  D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis
Journal:  Psychopharmacology (Berl)       Date:  2007-11-18       Impact factor: 4.530

9.  Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia.

Authors:  Shibley Rahman; Trevor W Robbins; John R Hodges; Mitul A Mehta; Peter J Nestor; Luke Clark; Barbara J Sahakian
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 10.  Frontotemporal lobar degeneration with TAR DNA-binding protein 43 (TDP-43): its journey of more than 100 years.

Authors:  Arenn F Carlos; Keith A Josephs
Journal:  J Neurol       Date:  2022-03-23       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.